stella
beta
Post-line Treatment With Teniposide for c-Myc-driven Extensive-stage Small Cell Lung Cancer — Stella
Recruiting
Back to Extensive-stage Small Cell Lung Cancer (ES-SCLC) trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
China
Shanghai Pulmonary Hospital, Shanghai, China, Shanghai, Shanghai Municipality
View full record on ClinicalTrials.gov